IJCRR - 5(1), January, 2013
Pages: 58-63
CARTILAGE METABOLIC MARKERS AND ANTIOXIDANTS: ITS CORRELATION IN OSTEOARTHRITIC PATIENTS OF SIKKIM
Author: Sonam Choden Bhutia, T. A. Singh, Mingma Lhamu Sherpa
Category: Healthcare
[Download PDF]
Abstract:
Background: Oxidative stress has been implicated as a mediator of cartilage damage in patient with Osteoarthritis (OA). Aim: To assess the antioxidant markers like superoxide dismutase (SOD) , glutathione peroxidase (GPx) and uric acid (UA) in the blood and cartilage metabolic markers like hyaluronic acid (HA) and keratan sulphate (KS) in the synovial fluid of osteoarthritic patients and to find the correlation between these parameters in the blood and synovial fluid. Methods: This was an observational study conducted in the department of Biochemistry, Sikkim Manipal Institute of Medical Sciences (SMIMS), Gangtok. 75 osteoarthritic patients and healthy volunteers were taken for the study. Blood levels of antioxidants (SOD, GPx and UA) were assayed in both osteoarthritic and healthy volunteers. Cartilage metabolic markers like HA and KS were assayed in the synovial fluid. Result: Osteoarthritic patients showed statistically significant increase in KS and decrease in HA level indicating cartilage damage. Decrease in SOD and GPx activities indicates increase in oxidative stress. The difference in UA levels in the two groups was not statistically significant. This study did not establish any significant positive/negative correlation between the antioxidants in the blood and cartilage metabolic markers in the synovial fluid of osteoarthritic patients.
Keywords: Osteoarthritis, cartilage metabolic markers, Antioxidants, GPx, SOD
Citation:
Sonam Choden Bhutia, T. A. Singh, Mingma Lhamu Sherpa. CARTILAGE METABOLIC MARKERS AND ANTIOXIDANTS: ITS CORRELATION IN OSTEOARTHRITIC PATIENTS OF SIKKIM International Journal of Current Research and Review. 5(1), January, 58-63
References:
1. Lutzner J, Kasten P, Gunther KP, Kirschner S.Surgical options for patients with Osteoarthritis of the knee. Nat Rev Rheumatol 2009; 5:309-16.
2. Sharma MK, Swami HM, Bhatia V, Verma A, Bhatia SP, Kaur G. An Epidemiological study of correlates of Osteoarthritis in Geriatric population of UTChandigarh. Indian J.Community Med.2007; 32:77-8
3. Syed A.HAQ, Fereydoun Davatchi. Osteoarthritis of the knees in the COPCORD world International Journal of Rheumatic Disease.2011; 14(2): 122-129.
4. T.Aigner, J.Haag, J.Martin, J.Buckwalter. Osteoarthritis: aging of matrix and cellsgoing for a remedy. Current Drug Targets 2007; 8(2): 325-331.
5. T.Aigner, N Gerwin. Growth plate cartilage as developmental model in osteoarthritis research potentials and limitations. Current Drug Targets 2007;8 (2):377-385
6. P. M. Van der Kraan, E. N. Blaney Davidson, W. B. van den Berg. A role for age-related changes in TGF beta signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Research and Therapy 2010; 12(1):201-214.
7. Thonar EJ-MA, Manicourt D-H. Noninvasive markers in Osteoarthritis. In Osteoarthritis: Diagnosis and Medical/ Surgical Management, 3 ed. Edited by Markowitz R, Goldberg V, Vowell DS, Altman RD, Buckwalter J. Philadelphia, and PA: WB Saunders; 2001:293-313.
8. Budsberg SC, Lenz ME, Thonar E. Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial ligament transaction. Am J Vet Res 2006; 67: 429-32.
9. Van den Bekerom MP, Lamme B, Sermon A, Mulier M. What is the evidence for Viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature.Arch Orthop Trauma Surg 2008; 128(8):815-823.
10. Turan Y, Bal S, Gurgan A, Topac H, Koseoglu M. Serum hyaluronan level in patients with knee Osteoarthritis .Clin Rheumatol 2007; 26:1293-8.
11. TAS F,Hansel H,Belce A,Ilvan S, Argon A, Camlica H , et al. Oxidative stress in ovarian cancer. Med Oncol.2005; 22(1):11- 15.
12. Mezes M, Bartosiewicz G. Investigations on vitamin E and lipid peroxide status in rheumatic diseases .Clin Rheumatol 1983; 2:259-63.
13. Ostalwska A,BirknerE,Wiecha M, Kasperczyk S,Kaspercyzk A,Kapolka D et al. Lipid peroxidation and antioxidant enzyme in synovial fluid of patients with primary and secondary Osteoarthritis of the knee joint. Osteoarthritis Cartilage 2006; 14:139-45.
14. Campo GM, Avenoso A, Nastasi G, Micali A, Prestipino V, Vaccaro M, et al. Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression. Biochem Biophys Acta 2011 Sep; 1812 (9):1170-81.
15. Altman R, Asch E,Bloch D,Bole G, Borenstein D, Brandt k et al. Development of criteria for the classification and reporting of Osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29:1039-1049.
16. Trinder P. Ann.Clin.Biochem 1969; 6:24- 27.
17. Woolliams JA, Wiener G, Anderson PH, Mc Murray CH. Research in Veterinary Science 1983; 34:253-256.
18. Paglia, D.E and Valentine, W.N., J.Lab. Clin. Med 1967; 70:158.
19. Shanghai Bluegene Biotech CO., Ltd. Human Hyaluronic acid Elisa kit and Human keratan sulphate Elisa kit. Cat number- E01H0004, E0590HU. lot #20110815.
20. Hooiveld, M.J.J., Roosendaal G, Vanden Berg, H.M, Lafeber et al. J.W.J Poster 47th Annual meeting. Orthopaedic Research Society, San Francisco, California. 2001: P- 455.
21. M Maneesh, Jayalekshmi, T Suma, S Chatterjee, A Chakrabarti, T.A.Singh. Evidence of oxidative stress in Osteoarthritis; Indian Journal of clinical Biochemistry 2005; 20(1):129-3.
22. Kalaci A, Yilmaz HR, Aslan B, Sogut S, Yanat AN, Uz E .Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritis. Clinical Rheumatol 2007 Aug; 26(8):1306-11.
23. Sautin, Yuri; Johnson, Richard. "Uric Acid: The Oxidant-Antioxidant Paradox". Nucleosides, Nucleotides and Nucleic Acids 2008; 27 (6): 608–19.
24. G.M.Rao, Sreelaxmi, A.Naser, Vandana. Reduced blood glutathione in erythrocyte stability in osteoarthritis. Biomedical Research 2005; 16(3):201-203.
25. Y Sun, H Brenner, S Sauerland, K.P.Gunther, W.Puhl, T.Sturmer. Serum uric acid and patterns of radiographic osteoarthritis – the Ulm Osteoarthritis Study. Scandinavian Journal of Rheumatology 2000; 29 (6):380-386
26. Dahl B, Dahl LM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid form patient with Rheumatoid Arthritis and other arthropies .Ann Rheum Dis1985;44:817-22
27. Balazs, EA. The physical properties of synovial fluid and the specific role of Hyaluronic acid. In: Helfet AJ, edition.In. In Disorders of the knee.Philadelphia: JB Lippincott; 1982.pp.61-74.
28. Van den Bekerom MP, Mylle G, Rys B, Mulier M. Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients. Acta Orthop Belg 2006; 72 (5):560-568.
29. Mehrabaan F, Finnegan CK, Markowitz RW.Serum keratan sulfate quantitative and qualitative comparison in inflammatory versus no inflammatory arthritides. Arthritis Rheum 1991; 34:383-92.
30. Campion GV, Mc Crae F, Schnitzler TJ, Lenz ME, Dieppe PA, Thonar EJ. Levels of keratan sulphate in the serum and synovial fluid patients with osteoarthritis of the knee .Arthritis Rheum1991; 34:1254-9.
31. Wakiteni S, Nawata M, Kawaguchi A, T Okabe, k.Takaoka, T.Tsukchiya, et al. Serum keratan sulphate is a promising marker of early cartilage breakdown. Rheumatology 2007 Nov; 46(11):1652-6.
32. Thonar EJ, Lenz ME, Klintworth GK, Caterson B, Pachman LM, Glickman P, et al. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum 1985; 28:1367-76.
|